Skip to content
healthcare.dev

Furosemide

NDC 10135-832, FUROSEMIDE, tablet, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-832
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA018569
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-832 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FUROSEMIDE20 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
10135-832-0110135083201100 TABLET in 1 BOTTLE (10135-832-01)
10135-832-10101350832101000 TABLET in 1 BOTTLE (10135-832-10)
10135-832-901013508329090 TABLET in 1 BOTTLE (10135-832-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4bd1b15e-354e-051f-e063-6294a90a3f3b

Use it

Look up 10135-832 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-832 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-832. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.